Application of Intensive Insulin Therapy, Chapter 9 – Part 3 Steve V. Edelman, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego Robert R. Henry, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego     The goals of therapy …

Assessment of the Treatment Regimen, Part 4 Steve V. Edelman, MD Robert R. Henry, MD Applying SMBG Results to Adjust Insulin Doses Patients can be taught how to analyze and use SMBG data to effectively make adjustments in their insulin doses so that they can maintain and improve glycemic control…. …

Combination Therapy, Chapter 9 – Part 4 Steve V. Edelman, MD Robert R. Henry, MD Combination therapy usually refers to the use of oral antidiabetic agents (daytime) together with a single injection of intermediate-acting or long-acting insulin at bedtime. The rationale for using an evening-insulin strategy is based on the …

Acute Complications: Metabolic – DKA Steve V. Edelman, MD Robert R. Henry, MD The most common acute complications of diabetes are metabolic problems (DKA, HHNS, hypoglycemia) and infection. In addition, the quality of life of patients with chronic and severe hypoglycemia is adversely affected. Characteristic symptoms of tiredness and lethargy …

Multiple-Injection Regimens, Chapter 9 – Part 5 Steve V. Edelman, MD Robert R. Henry, MD One of the more common insulin regimens utilized in Type 2 diabetes mellitus is a split-mixed regimen consisting of a prebreakfast and predinner dose of an intermediate- and a fast-acting insulin. This split-mixed regimen of …

Insulin-Pump Therapy + New Types of Insulin Preparations + Complications of Insulin Therapy, Chapter 9 – Part 6 Steve V. Edelman, MD Robert R. Henry, MD Insulin-Pump Therapy Insulin-pump therapy has been traditionally used for people with Type 1 diabetes. People with Type 1 diabetes usually do not have insulin …

Pramlintide Therapy, Chapter 11 – Part 1 Steve V. Edelman, MD Robert R. Henry, MD The discovery of insulin over 80 years ago is one of the great success stories in the history of modern medicine.  Although insulin remains the mainstay of therapy for many patients with diabetes, the greatest …

Insulin Therapy, Chapter 9 – Part 1 Steve V. Edelman, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego Robert R. Henry, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego   Insulin therapy most commonly is reserved for patients …

…tells his patients, “The recent reports from Europe regarding Lantus being associated with cancer do not represent anything close to a proper scientific analysis.”

Combination Therapy: Oral medications during the day and Lantus at night